Directory · ES
Biotechnology in Spain
A register of firms and the professionals working at them in the Biotechnology sector based in Spain. Browse the public index, then filter or export on Kipplo.
Companies
195 on file
Kamleon
Based in Barcelona, Kamleon is a science-based early-stage company developing user-centered technologies that aims to motivate people to live better by democratizing the monitoring of wellbeing – "Everywhere, anywhere".
1 to 10 staff
Linear Chemicals, S.L.U
LINEAR CHEMICALS, S.L.U. is a Spanish company established in early 1994 with activities in the developing, manufacturing of In Vitro Diagnostics (IVD) products including different Instruments and Reagents covering Clinical Chemistry, Serology, Urinalysis, Haematology and Immunology and marketing them under the brand name Cromatest®, Clonatest®, Cromavet®, Plus-Sed®, Linear® and Gerbion®. LINEAR CHEMICALS, S.L.U. es una empresa española establecida a principios de 1994 cuya actividad se centra en el desarrollo y fabricación de productos para el Diagnóstico In Vitro. Nuestro catálogo de productos incluye instrumentación y reactivos para Química Clínica, Serología, Análisis de Orina, Hematología e Inmunología, comercializados con nuestras marcas registradas Cromatest®, Clonatest®, Plus-Sed® Linear® y Gerbion®.
51 to 200 staff
Microptic
MICROPTIC, company based in Barcelona, is a leading player in the field of research, design, development, sale, installation and service of in-vitro diagnostic systems. Using Artificial Intelligence technology, we are specialized in semen analysis. Our “Sperm Class Analyzer® - SCA®” CASA System is a state-of-the-art technology for the sperm analysis that is used in the routine and research in the most reputed centres worldwide. There are several configurations of the same, adapted for human, animal production, research and toxicology. And our Karyotyping and FISH MetaClass is a user-friendly solution for human cytogenetic studies. Microptic S.L. is 9001 and 13485 ISO certified.
11 to 50 staff
Mikrobiomik
Mikrobiomik is a bio-pharmaceutical company founded to conduct research into and develop medicines based on the human microbiome. Our vision We aspire to be the first company in the world to market a medicine based on faecal microbiota in the EU. To that end, we are holding talks with both the EMA (European Medicines Agency) and the AEMPS (Spanish Agency for Medicines and Health Products) with a view to establishing protocols on the regulatory requirements for securing an MAA (Marketing Authorization Application) via centralised procedure. Our values Mikrobiomik seeks to lead the paradigm shift entailed by designing therapeutic solutions based on the human microbiome through excellence in its processes, empathising with chronic patients for whom no curative treatments are available, always from the perspective of networking with all stakeholders in the sector.
11 to 50 staff
Asparia Glycomics
Asparia Glycomics is a leading Glycotechnology company with cutting edge solutions for glycoscience R&D. We offer custom synthesis services for complex oligosaccharides and glycopeptides and precision glycan analysis services by mass spectrometry and in house lectin microarrays. In addition, we develop and commercialize speciality reagents and enzymes for glycan analysis like our unique Carboquant 13C labelled glycan standards for quantitative glycan analysis by MALDI-TOF MS. Contact us at contact@aspariaglycomics.com
1 to 10 staff
Baigene
El Método Baigene es un servicio innovador y único. Se basa en personalizar al máximo y optimizar la actividad física y la nutrición mediante el cálculo de la dosis mínima efectiva de ejercicio y de una dieta 100% personalizada. Esto lo conseguimos a través del análisis de la genética con nuestro test propio y midiendo otras variables de la persona: valoración morfofuncional, test de fuerza, valoración corporal, etc. El objetivo del cliente puede ser mejorar su salud y/o su rendimiento. BaigeneLAB es la instalación física en la que se realiza la valoración INTEGRAL del cliente y donde se trabaja cara a cara con el entrenador Baigene 30 minutos a la semana. Actualmente tenemos BaigeneLabs en España y The Baigene Method is an innovative and unique service. It is based on fully personalizing and optimizing physical activity and nutrition by calculating the minimum effective dose of exercise and a 100% personalized diet. We achieve this by analyzing genetics with our own test and other variables of the person: morphofunctional assesment, strenght test, corporal assesment, etc. The client's goal may be to improve their health and / or sport performance. BaigeneLAB is the physical facility in which the INTEGRAL assessment of the client is carried out and where they work one to one with the Baigene coach 30 minutes a week. We currently have BaigeneLabs in Spain and Bahrain.
1 to 10 staff
Bdr- Blackhills Diagnostic Resources
Blackhills Diagnostic Resources S.L.U.(BDR) is a Spanish biotech company founded in 2012 focused on developing, manufacturing and commercializing CE-IVD products for human diagnostic. The company is ISO 13485:2016 and EN ISO 13485:2016 certified. BDR counts with a wide experience in Real Time PCR and fragment analysis techniques apply to HLA and rare disease fields. Both technologies constitute Genvinset® and Adellgene® product lines. Moreover, it offers its own software development for results interpretation and data management system at transplant laboratories. BDR works steadily to expand its business national and internationally, both with its own brand and OEM/bulk business model. Among our main customers there are public and private reference hospitals and laboratories.
1 to 10 staff
Bioquochem Bqc Redox Technologies
BQC is a biotechnology company specialized in the development and design of kits and electrochemical devices for the measurement of redox parameters. About our devices, we have the BRS (BQC Redox system) for total antioxidant capacity measurement biomedical and in food, beverages and plant-based samples! Furthermore, we offer a wide range of kirs for measuring redox parameters such as antioxidant capacity, oxidative stress, biomolecule damage, phenolic compounds, ROS sensors, among others. We are also able to design new kits adapted to the needs of our customers. BQC is specially committed to offering the best service to our customers, having particular regard to technical assistance before and after the acquisition of our products. Something remarkable is that our products are reasonably priced, but always maintain the highest quality standards. Finally, as the company is aware of the value of time, we have excellent courier and distributors to guarantee that the order arrives within 3-6 days from the confirmation of the purchase. For more information visit our website: or contact at: support@bqcredox.com
11 to 50 staff
Sener Diagnostics
Through a disruptive and provocative vision of laboratory automation, and with the client at the center of our operations, we offer innovative, value-added solutions to automate laboratory workflows in the fields of microbiology and molecular biology. Through OEM or CDMO partnerships, we offer the complete product lifecycle, from VoC analysis to after-sales service, including the entire design, development, clinical validation, manufacturing, and certification and registration process. We belong to the private engineering and technology group Sener which, founded in 1956, strives to offer its customers the most advanced technological solutions and is internationally recognized for its commitment to innovation, quality, and independence.
11 to 50 staff
Aniling
At Aniling, we are committed to bringing advances in the Genomics arena to everyday health care and disease prevention. We aim to accelerate epigenomics to help make precision medicine a reality. Aniling has patented the GEUS technology (Genomic and Epigenomic Unified Sequencing), which allows for the rst time simultaneous and high-reliability analysis of genome and epigenome, and provides end-to-end solutions for the right treatment decisions in oncology. Our company is a spin-off of the Institute of Predictive and Personalized Medicine of Cancer (IMPPC), currently integrated in the Germans Trias i Pujol Biomedical Research Institute (IGTP). Aniling has offices and laboratories in the IGTP and full access to shared resources and facilities of the Can Ruti Campus, which includes the Hospital Germans Trias i Pujol, the Autonomous University of Barcelona and five biomedical research institutes (IGTP, IRSICaixa, IJC, Guttmann Institute and ICO).
1 to 10 staff
Bioingenium, S.L
Bioingenium is a preclinical Contract Development and Manufacturing Organization (CDMO) specializing in protein expression. Bioingenium has more than 15 years of experience in designing and developing tailor-made bioprocesses, recombinant therapeutic proteins, and natural ferments based on microbial systems and animal cells. We bridge the gap between R&D and GMP production. OUR SERVICES: Biopharmaceuticals / Biotech / IVD companies: • Recombinant protein production, cell line, and strain development. o Full process development at the preclinical phase: upstream processes from scratch and its optimization. o Design of customized purification processes. • Bioprocess scale-up and production. We have a protein production plant with a capacity of up to 200 liters of fermentation. • Preclinical batch production. • Quality control analysis. • Sterile Reagents production: o Proteins (cellular differentiation factors) for Cell Therapy, o DNA modifying Enzymes (restriction enzymes, polymerases) for Gene Therapy, o mRNA Manufacturing enzymes (Restriction enzymes, polymerases) for mRNA Vaccines. • Production of proteins and antigens for IVD companies. Cosmetics: • Development and production of active ingredients based on ferments, microorganism lysates, and culture supernatants. Food industry: • Development of alternative proteins, precision fermentation. • Industrial enzymes: proteases, lipases, amylases, transglutaminases, and catalases.
11 to 50 staff
Oscillum
Oscillum is a biotechnology company founded in Alicante in 2019. At Oscillum, we develop innovative and scientifically rigorous biotechnological solutions that optimize your resources, improve decision making and extend the shelf life of perishable products. Our mission is to provide complementary packaging solutions that meet the needs of the industry and consumers, making the technology accessible and understandable, and ensuring support at every step of the process.
1 to 10 staff
Abilitypharma
Ability Pharmaceuticals is a clinical-stage biopharmaceutical company committed to develop first-in-class therapies that address unmet medical needs in the oncology space. AbilityPharma's is currently conducting, with ABTL0812, the most advanced asset, an international multi-center, double-blind, placebo-controlled phase 2b clinical trial in patients with metastatic pancreatic cancer to investigate ABTL0812 as first-lin therapy in combination with FOLFIRINOX chemotherapy. The study includes reference centers in Spain, France, United States and Israel. ABTL0812 has finished with very positive results a phase 2a clinical trial as first-line therapy in endometrial cancer and in squamous NSCLC in combination with paclitaxel and carboplatin. The study included leading institutions in Spain and France (Vall d’Hebron Institut d’Oncologia – VHIO, Institut Gustave Roussy, Centre Léon Bérard). ABTL0812 is the first cancer drug killing tumor cells through potent cytotoxic autophagy via inhibition of the Akt/mTOR axis, and the induction of robust endoplasmic reticular stress (ER Stress). Its unique mechanism of action was partially published at Clinical Cancer Research in December 2015 and fully characterized at Autophagy journal in May 2020. The compound has also immunomodulatory effects, turning "cold" immunogenic tumors into "hot" immunogenic. The compound is active as standalone treatment, it has synergy with chemotherapy, and it has synergy with anti PD1 therapies. The product has potential in several cancer types as first-line and maintenance therapy including lung, endometrial, pancreatic, breast, head and neck cancer, glioblastoma, cholangiocarcinoma and the pediatric cancer neuroblastoma. ABTL0812 has been granted Orphan Drug Designation for pancreatic cancer, neuroblastoma, and biliary tract cancer, by the US FDA and the European EMA. Development and marketing rights for Greater China granted to SciClone Pharmaceuticals, Inc.
11 to 50 staff
Araclon Biotech, S.L
At Araclon Biotech, a Grifols company, we focus on the early diagnosis and preventive treatment of Alzheimer’s disease. We are pioneers in plasma-based assays for detecting amyloid peptides and have developed ABvac40, an innovative vaccine targeting Aβ40 to slow disease progression. Since our founding in 2004 by Prof. Manuel Sarasa Barrio as a spin-off from the University of Zaragoza, we have grown into a leader in Alzheimer’s research, committed to scientific excellence and innovation. As part of Grifols, we continue to develop groundbreaking solutions that improve the lives of individuals affected by neurodegenerative diseases.
11 to 50 staff
Bcn-Medtech
The Barcelona Centre for New Medical Technologies, BCN-MedTech, was created on July 6th 2016 within the university’s Department of Information and Communication Technologies (DTIC) to provide an interdisciplinary and translational platform for research in biomedical engineering. It arose from the conviction that the rapid and exponential development of medical technology must be understood from a comprehensive technological, clinical, social and industrial perspective if it is to have a true impact on the many areas of application in the healthcare sector. BCN-MedTech provides a comprehensive coverage of all core MedTech technologies. We have experience with signal processing, imaging, physiology, biomechanics, electronics, biomedical simulations, and computer-assisted surgery Based on open innovation methodologies, we support your company in identifying and developing novel technologies and products. We participate and coordinate large international projects exploring and expanding the state of the art. Join us in defining the future! Your company can obtain very valuable knowledge and networks through the participation in collaborative research projects.
51 to 200 staff
Biotools B&m Labs, S.A
For over 18 years, Biotools has been offering scientists, technicians and researchers a wide range of molecular biology kits and reagents for the life sciences research and clinical laboratories markets, meeting most of our customers' needs. Our extensive experience and expertise in the PCR technique makes us leaders in the academic, industrial and government research sectors, providing cost effective and practical products.
11 to 50 staff
Granada Salud
El objetivo de Granada Salud es comunicar el potencial del territorio de Granada como motor de la innovación en el sector Salud. La iniciativa Granada Salud es un esfuerzo conjunto de las diferentes organizaciones públicas y privadas que promueven la ciencia y la innovación en materia de salud en Granada, y organiza la oferta de servicios existentes en el territorio para facilitar su conocimiento a cualquier entidad o persona interesada
1 to 10 staff
Mycointech
Mycointech is an innovative microbial raw material manufacturer that produces endo, ecto and ericoid mycorrhizal fungi, bacteria and customized finished biological products to the agriculture, horticulture and fertilizer industries. We have developed proprietary technology that allows us to produce viable mycorrhizae through an in-vivo process, resulting in consistent, high-quality inoculum available in customizable concentrations and blends. We also offer consulting to companies looking to optimize their formulations by adding biological components to their products.
11 to 50 staff
Oxolife
Oxolife is a biotechnology company dedicated to enhancing female fertility, with a focus on embryo implantation in women undergoing assisted reproductive technologies (ART). We are developing OXO-001, a first-in-class, non-hormonal oral treatment that directly targets the endometrium, enhancing embryo implantation and increasing Live Birth Rates (LBR). This innovative approach addresses an unmet medical need, as no drug currently exists to specifically increase embryo implantation rates, accounting for 65% Embryo Transfer failures. OXO-001 stands out due to its unique mechanism of action, offering a groundbreaking solution in the fertility space. Following the completion of our Phase II clinical trial, the results have been highly promising, demonstrating a strong balance of efficacy and safety, increasing LBR by 6.9%. These findings position Oxolife to move confidently toward the final stages of clinical development to bring this essential treatment to market, backed by a portfolio of global patents. In addition to our work with OXO-001, we are conducting research aimed at restoring fertility in women affected by polycystic ovarian syndrome (PCOS), a common cause of infertility. Our vision is to improve the chances of live birth for women with infertility, significantly reducing the stress and financial burden associated with infertility treatments for women and couples worlwide. Oxolife is led by Agnès Arbat, MD (Co-founder and CEO), and Ignasi Canals, PhD in Biochemistry (Co-founder and CSO). Together with Oxolife a multidisciplinary, diverse, and high-skilled team, supported by an exceptional international Advisory Board, that has built a robust network of partnerships with key fertility clinics and research institutions, we bring extensive experience in women’s health, pharmaceutical innovation, and drug development.
1 to 10 staff
Splicebio
SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research by our co-founders. The company is backed by UCB Ventures, Ysios Capital, NEA, Gilde Healthcare, Novartis Venture Fund and Asabys Partners.
11 to 50 staff
Unidesa-Odi Union Dental
In Unidesa we believe firmly in our values. Highest Quality and Experience. This values goes belong the paper, it still in force in every situation we are involve, are the ideals that conform and guide our actions with our clients. They remember us what we do and where we came from. Highest Quality and Experience. This values determinate every aspect of this family company, constitute the essence of our corporate culture, unique and inimitable. We understand that they become a competitive advantage. Although, are good by themselves, are useful and make us feel proud of belong to this big Company that produce with quality from more than half a century. Mission: Continue to produce high quality dental products with inalterable aesthetic and technical characteristics to be useful worldwide. Quality: For us, Quality is contrastable results and the approval of the strictest international certifications. Quality is being conscious of the necessity of a continued technological adaptation without losing our handcraft spirit. With this results we get the reliability in our high-level products that shows a natural aesthetic inalterable that allow us to be competitive with an average production of 15 millions of units per year. Experience: For us, Experience is being conscious of the responsibility of continue a 60 years legacy exporting our products “made in Spain”. Experience is putting our knowledge to the service of our clients, improving day by day out production system. We are one of the first automatized factory in Europe, what convert us in pioneers in our sector. The export experience in 50 countries give us the security to know that our relation with our clients is solid thanks to our constant solutions to their necessities. We have found the perfection through the experience and we are very proud about it.
51 to 200 staff
Ambe Medical Systems
Somos una empresa especializada en servicios técnicos de electromedicina en España con una trayectoria de más de 20 años en la industria. Durante este tiempo, hemos brindado soluciones técnicas a diversas multinacionales y fabricantes de tecnología médica, consolidándonos como líderes en el campo de la electromedicina Ambe Medical Systems. Nuestro equipo técnico está compuesto por profesionales altamente capacitados y especializados en el área de la electromedicina. Nos mantenemos constantemente actualizados con los avances y las tendencias más recientes de la industria para garantizar que podamos proporcionar el mejor servicio a nuestros clientes. Ofrecemos una amplia gama de servicios que incluyen reparación, mantenimiento y calibración de equipos de electromedicina. Ya sea que necesite asistencia con equipos de diagnóstico, monitores de signos vitales, sistemas de imagen médica o cualquier otro dispositivo médico, podemos brindarle soluciones eficientes y confiables. Utilizamos herramientas y tecnología de vanguardia para llevar a cabo estos servicios. Asegurando que los equipos funcionen de manera óptima y con la máxima precisión. Ambe Medical Systems Entendemos que los equipos de electromedicina desempeñan un papel fundamental en la atención médica y la vida de los pacientes. Por lo tanto, nos esforzamos por ofrecer un servicio rápido, eficiente y confiable para minimizar cualquier interrupción en la operación de estos equipos vitales. Nuestro objetivo es garantizar la disponibilidad y el rendimiento óptimo de los equipos médicos. Lo que contribuye directamente a mejorar la calidad de la atención y el bienestar de los pacientes. Además de nuestros servicios técnicos, hemos establecido una red confiable de proveedores y colaboradores en la industria de la electromedicina. Esto nos permite tener acceso a piezas de repuesto originales y recursos técnicos de primera calidad, lo que nos permite brindar un servicio aún más eficiente y confiable.
1 to 10 staff
Amc Chemical
AMC Chemical es una empresa dedicada a la biotecnología que ofrece soluciones tecnológicas y productos de vanguardia para una agricultura sostenible y de futuro.
11 to 50 staff
Bioclonal
BioClonal is focused in Antibody Discovery, offering customized solutions tailored to each specifics needs and goals in the therapeutic mAbs area. Proprietary development: FIC for Alzheimer's Disease We partner with pharmaceutical and biotechnology companies worldwide, thanks to our innovative in vivo platform, RedMabs. Based in a win- win philosophy, we propose long-term agreements of co-discovery and co-development.
1 to 10 staff
